Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease
Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an extracellular...
Saved in:
Published in | Journal of translational medicine Vol. 16; no. 1; p. 159 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
08.06.2018
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein, which is highly expressed in the heart and arteries and recently introduced as a potential mediator of pathological vascular remodeling and neointima formation. We aimed to investigate the relationship between serum MFAP4 (sMFAP4) and symptomatic PAD outcomes.
A total of 286 PAD patients were analyzed if they had either intermittent claudication or critical lower-extremity ischemia (CLI) and followed for 7 years. The level of serum MFAP4 (sMFAP4) was measured by alphaLISA. Kaplan-Meier, Cox proportional hazard and logistic regression analysis were used to analyze the associations between upper tertile sMFAP4 and symptomatic PAD outcomes.
Patients with upper tertile sMFAP4 had an odds ratio (OR) of 2.65 (p < 0.001) for having CLI diagnosis. Further analysis indicated that patients with upper tertile sMFAP4 had a hazard ratio (HR) of 1.97 (p = 0.04) for cardiovascular death during the 7-years follow-up. However, analysis of 2-year primary patency showed that patients with upper tertile sMFAP4 had decreased risk of vascular occlusion after reconstructive surgery with HR of 0.15 (p = 0.02).
sMFAP4 has potential as a prognostic marker for cardiovascular death, primary patency of reconstructed vessels and CLI diagnosis in symptomatic PAD patients. Confirmation of observations in larger cohorts is warranted. |
---|---|
AbstractList | Abstract Background Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein, which is highly expressed in the heart and arteries and recently introduced as a potential mediator of pathological vascular remodeling and neointima formation. We aimed to investigate the relationship between serum MFAP4 (sMFAP4) and symptomatic PAD outcomes. Methods A total of 286 PAD patients were analyzed if they had either intermittent claudication or critical lower-extremity ischemia (CLI) and followed for 7 years. The level of serum MFAP4 (sMFAP4) was measured by alphaLISA. Kaplan–Meier, Cox proportional hazard and logistic regression analysis were used to analyze the associations between upper tertile sMFAP4 and symptomatic PAD outcomes. Results Patients with upper tertile sMFAP4 had an odds ratio (OR) of 2.65 (p < 0.001) for having CLI diagnosis. Further analysis indicated that patients with upper tertile sMFAP4 had a hazard ratio (HR) of 1.97 (p = 0.04) for cardiovascular death during the 7-years follow-up. However, analysis of 2-year primary patency showed that patients with upper tertile sMFAP4 had decreased risk of vascular occlusion after reconstructive surgery with HR of 0.15 (p = 0.02). Conclusions sMFAP4 has potential as a prognostic marker for cardiovascular death, primary patency of reconstructed vessels and CLI diagnosis in symptomatic PAD patients. Confirmation of observations in larger cohorts is warranted. BACKGROUNDSymptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein, which is highly expressed in the heart and arteries and recently introduced as a potential mediator of pathological vascular remodeling and neointima formation. We aimed to investigate the relationship between serum MFAP4 (sMFAP4) and symptomatic PAD outcomes.METHODSA total of 286 PAD patients were analyzed if they had either intermittent claudication or critical lower-extremity ischemia (CLI) and followed for 7 years. The level of serum MFAP4 (sMFAP4) was measured by alphaLISA. Kaplan-Meier, Cox proportional hazard and logistic regression analysis were used to analyze the associations between upper tertile sMFAP4 and symptomatic PAD outcomes.RESULTSPatients with upper tertile sMFAP4 had an odds ratio (OR) of 2.65 (p < 0.001) for having CLI diagnosis. Further analysis indicated that patients with upper tertile sMFAP4 had a hazard ratio (HR) of 1.97 (p = 0.04) for cardiovascular death during the 7-years follow-up. However, analysis of 2-year primary patency showed that patients with upper tertile sMFAP4 had decreased risk of vascular occlusion after reconstructive surgery with HR of 0.15 (p = 0.02).CONCLUSIONSsMFAP4 has potential as a prognostic marker for cardiovascular death, primary patency of reconstructed vessels and CLI diagnosis in symptomatic PAD patients. Confirmation of observations in larger cohorts is warranted. Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein, which is highly expressed in the heart and arteries and recently introduced as a potential mediator of pathological vascular remodeling and neointima formation. We aimed to investigate the relationship between serum MFAP4 (sMFAP4) and symptomatic PAD outcomes. A total of 286 PAD patients were analyzed if they had either intermittent claudication or critical lower-extremity ischemia (CLI) and followed for 7 years. The level of serum MFAP4 (sMFAP4) was measured by alphaLISA. Kaplan-Meier, Cox proportional hazard and logistic regression analysis were used to analyze the associations between upper tertile sMFAP4 and symptomatic PAD outcomes. sMFAP4 has potential as a prognostic marker for cardiovascular death, primary patency of reconstructed vessels and CLI diagnosis in symptomatic PAD patients. Confirmation of observations in larger cohorts is warranted. Background Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein, which is highly expressed in the heart and arteries and recently introduced as a potential mediator of pathological vascular remodeling and neointima formation. We aimed to investigate the relationship between serum MFAP4 (sMFAP4) and symptomatic PAD outcomes. Methods A total of 286 PAD patients were analyzed if they had either intermittent claudication or critical lower-extremity ischemia (CLI) and followed for 7 years. The level of serum MFAP4 (sMFAP4) was measured by alphaLISA. Kaplan–Meier, Cox proportional hazard and logistic regression analysis were used to analyze the associations between upper tertile sMFAP4 and symptomatic PAD outcomes. Results Patients with upper tertile sMFAP4 had an odds ratio (OR) of 2.65 (p < 0.001) for having CLI diagnosis. Further analysis indicated that patients with upper tertile sMFAP4 had a hazard ratio (HR) of 1.97 (p = 0.04) for cardiovascular death during the 7-years follow-up. However, analysis of 2-year primary patency showed that patients with upper tertile sMFAP4 had decreased risk of vascular occlusion after reconstructive surgery with HR of 0.15 (p = 0.02). Conclusions sMFAP4 has potential as a prognostic marker for cardiovascular death, primary patency of reconstructed vessels and CLI diagnosis in symptomatic PAD patients. Confirmation of observations in larger cohorts is warranted. Background Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein, which is highly expressed in the heart and arteries and recently introduced as a potential mediator of pathological vascular remodeling and neointima formation. We aimed to investigate the relationship between serum MFAP4 (sMFAP4) and symptomatic PAD outcomes. Methods A total of 286 PAD patients were analyzed if they had either intermittent claudication or critical lower-extremity ischemia (CLI) and followed for 7 years. The level of serum MFAP4 (sMFAP4) was measured by alphaLISA. Kaplan-Meier, Cox proportional hazard and logistic regression analysis were used to analyze the associations between upper tertile sMFAP4 and symptomatic PAD outcomes. Results Patients with upper tertile sMFAP4 had an odds ratio (OR) of 2.65 (p < 0.001) for having CLI diagnosis. Further analysis indicated that patients with upper tertile sMFAP4 had a hazard ratio (HR) of 1.97 (p = 0.04) for cardiovascular death during the 7-years follow-up. However, analysis of 2-year primary patency showed that patients with upper tertile sMFAP4 had decreased risk of vascular occlusion after reconstructive surgery with HR of 0.15 (p = 0.02). Conclusions sMFAP4 has potential as a prognostic marker for cardiovascular death, primary patency of reconstructed vessels and CLI diagnosis in symptomatic PAD patients. Confirmation of observations in larger cohorts is warranted. Keywords: MFAP4, Peripheral artery disease, Mortality, Primary patency, Lower-extremity ischemia Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is atherosclerosis, vascular dysfunctions, impaired angiogenesis and neointima formation. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein, which is highly expressed in the heart and arteries and recently introduced as a potential mediator of pathological vascular remodeling and neointima formation. We aimed to investigate the relationship between serum MFAP4 (sMFAP4) and symptomatic PAD outcomes. A total of 286 PAD patients were analyzed if they had either intermittent claudication or critical lower-extremity ischemia (CLI) and followed for 7 years. The level of serum MFAP4 (sMFAP4) was measured by alphaLISA. Kaplan-Meier, Cox proportional hazard and logistic regression analysis were used to analyze the associations between upper tertile sMFAP4 and symptomatic PAD outcomes. Patients with upper tertile sMFAP4 had an odds ratio (OR) of 2.65 (p < 0.001) for having CLI diagnosis. Further analysis indicated that patients with upper tertile sMFAP4 had a hazard ratio (HR) of 1.97 (p = 0.04) for cardiovascular death during the 7-years follow-up. However, analysis of 2-year primary patency showed that patients with upper tertile sMFAP4 had decreased risk of vascular occlusion after reconstructive surgery with HR of 0.15 (p = 0.02). sMFAP4 has potential as a prognostic marker for cardiovascular death, primary patency of reconstructed vessels and CLI diagnosis in symptomatic PAD patients. Confirmation of observations in larger cohorts is warranted. |
ArticleNumber | 159 |
Audience | Academic |
Author | Sorensen, Grith L Schlosser, Anders Hemstra, Line Ea Lindholt, Jes Sanddal |
Author_xml | – sequence: 1 givenname: Line Ea surname: Hemstra fullname: Hemstra, Line Ea organization: Cancer and Inflammation Research, Department of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 3rd Floor, Odense, Denmark – sequence: 2 givenname: Anders surname: Schlosser fullname: Schlosser, Anders organization: Cancer and Inflammation Research, Department of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 3rd Floor, Odense, Denmark – sequence: 3 givenname: Jes Sanddal surname: Lindholt fullname: Lindholt, Jes Sanddal organization: Center of Individualized Medicine in Arterial Diseases (CIMA), Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark – sequence: 4 givenname: Grith L orcidid: 0000-0002-5273-1097 surname: Sorensen fullname: Sorensen, Grith L email: glsorensen@health.sdu.dk organization: Cancer and Inflammation Research, Department of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 25, 3rd Floor, Odense, Denmark. glsorensen@health.sdu.dk |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29884190$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk1v1DAQhi1URD_gB3BBkbhwSfFnbF-QqgraSkVcgKs1cSZbrzZxsLOV9t_XYUvpIk62x-884xm_p-RojCMS8pbRc8ZM8zEzbhtdU2ZqpriomxfkhElta2V0c_Rsf0xOc15TyqWS9hU55tYYySw9IT-_Bp9iH9oUNhtINeQcfYAZu2pKccYwVrK6h1RCIY5VOebdMM1xKGdfTZjCdIcJNhWkGdOu6kJGyPiavOxhk_HN43pGfnz5_P3yur79dnVzeXFbe9XQudaa08ZTxrTiuhfMgNXApe3AYgcAHrrWo-dKsoYaoaVtFZNUAadt71slzsjNnttFWLsphQHSzkUI7ncgppUrDwt-gw46NIUpFFgqkXPb90rIUlcJ1RuQhfVpz5q27YCdx3EujR1AD2_GcOdW8d4payUVrAA-PAJS_LXFPLshZI9lriPGbXacKm6oVEIX6ft_pOu4TWMZ1aJqrBTK0r-qFZQGwtjHUtcvUHehZGMst3Zhnf9HtcwOh-CLY_pQ4gcJbJ9Qfj7nhP1Tj4y6xVhubyxXjOUWY7mm5Lx7PpynjD9OEg-nb8qC |
CitedBy_id | crossref_primary_10_1016_j_jvs_2019_08_253 crossref_primary_10_1111_apm_12974 crossref_primary_10_3389_flupu_2024_1386256 crossref_primary_10_3350_cmh_2018_0029 crossref_primary_10_1016_j_ejvs_2024_05_029 crossref_primary_10_1183_23120541_00021_2019 crossref_primary_10_1002_jcp_29893 crossref_primary_10_1111_apm_13358 crossref_primary_10_3389_fcvm_2021_764337 crossref_primary_10_3389_fphys_2019_01112 crossref_primary_10_1186_s40001_023_01002_z crossref_primary_10_1159_000506827 crossref_primary_10_1177_13524585231200720 crossref_primary_10_1038_s42003_022_03140_2 crossref_primary_10_1177_11772719211016359 crossref_primary_10_1002_jgh3_12873 crossref_primary_10_1111_liv_14491 crossref_primary_10_1016_j_mehy_2020_110106 crossref_primary_10_3390_cells11132115 crossref_primary_10_1016_j_matbio_2022_05_008 |
Cites_doi | 10.1002/hep.22764 10.1111/j.1365-3083.2006.01778.x 10.1152/ajplung.00351.2014 10.1016/j.jvs.2011.11.061 10.1016/j.ijpara.2016.08.004 10.1016/j.atherosclerosis.2007.02.025 10.1016/j.jvs.2016.03.420 10.1001/jama.292.4.453 10.1097/01.hjr.0000277983.23934.c9 10.1016/j.jvs.2014.12.007 10.1177/1358863X12463491 10.1016/j.atherosclerosis.2011.02.016 10.1024/0301-1526.33.4.183 10.1177/1358863X15617541 10.1016/j.jacc.2015.12.049 10.1161/ATVBAHA.115.306672 10.1074/jbc.M115.681775 10.1016/j.clinbiochem.2016.05.023 10.1016/j.jvs.2014.12.006 10.1016/S1078-5884(96)80044-X 10.1186/s12931-014-0147-5 10.1186/s12967-016-0952-3 10.1016/j.jvs.2011.09.001 10.1001/jama.300.2.197 10.1371/journal.pone.0082243 10.1002/pro.2177 10.1016/j.jvs.2006.12.037 10.1136/thoraxjnl-2014-206609 10.3949/ccjm.73.Suppl_4.S2 10.1016/j.atherosclerosis.2011.09.016 10.1371/journal.pone.0140418 10.1101/cshperspect.a005058 10.3109/14017431.2014.891760 10.1002/bjs.9825 10.1016/j.atherosclerosis.2009.12.030 10.1093/eurheartj/eht288 10.1002/bjs.9848 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2018 BioMed Central Ltd. Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. The Author(s) 2018 |
Copyright_xml | – notice: COPYRIGHT 2018 BioMed Central Ltd. – notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2018 |
DBID | NPM AAYXX CITATION 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12967-018-1523-6 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts Immunology Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1479-5876 |
EndPage | 159 |
ExternalDocumentID | oai_doaj_org_article_ade8daa35a904e229ff534527535f8a4 A546892997 10_1186_s12967_018_1523_6 29884190 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Denmark |
GeographicLocations_xml | – name: Denmark |
GrantInformation_xml | – fundername: Lundbeckfonden (DK) grantid: j.nr R164-2013-15355 – fundername: The Danish Research Council grantid: DFF - 7016-00038 – fundername: Novo Nordisk grantid: NNF17OC0028222 – fundername: ; grantid: NNF17OC0028222 – fundername: ; grantid: j.nr R164-2013-15355 – fundername: ; – fundername: ; grantid: DFF - 7016-00038 |
GroupedDBID | --- -A0 0R~ 29L 2WC 3V. 53G 5VS 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX CITATION 7T5 7XB 8FK AZQEC DWQXO H94 K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c560t-77206c0117527f318a97a249da9edaaacadbcec25416083749b51405a20bfcb53 |
IEDL.DBID | RPM |
ISSN | 1479-5876 |
IngestDate | Tue Oct 22 15:07:02 EDT 2024 Tue Sep 17 21:08:50 EDT 2024 Thu Oct 24 22:47:51 EDT 2024 Thu Oct 10 18:49:51 EDT 2024 Tue Nov 19 20:59:35 EST 2024 Tue Nov 12 22:45:49 EST 2024 Thu Sep 12 18:06:53 EDT 2024 Wed Oct 16 00:48:35 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Peripheral artery disease MFAP4 Mortality Primary patency Lower-extremity ischemia |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c560t-77206c0117527f318a97a249da9edaaacadbcec25416083749b51405a20bfcb53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-5273-1097 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994031/ |
PMID | 29884190 |
PQID | 2056943590 |
PQPubID | 43076 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ade8daa35a904e229ff534527535f8a4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5994031 proquest_miscellaneous_2052804537 proquest_journals_2056943590 gale_infotracmisc_A546892997 gale_infotracacademiconefile_A546892997 crossref_primary_10_1186_s12967_018_1523_6 pubmed_primary_29884190 |
PublicationCentury | 2000 |
PublicationDate | 2018-06-08 |
PublicationDateYYYYMMDD | 2018-06-08 |
PublicationDate_xml | – month: 06 year: 2018 text: 2018-06-08 day: 08 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Journal of translational medicine |
PublicationTitleAlternate | J Transl Med |
PublicationYear | 2018 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | MC Stoner (1523_CR10) 2016; 64 J Jim (1523_CR6) 2012; 55 C Molleken (1523_CR27) 2009; 49 WR Hiatt (1523_CR17) 2012; 17 NU Hansen (1523_CR33) 2016; 49 TA Pereira (1523_CR34) 2016; 46 G Urbonaviciene (1523_CR37) 2011; 219 H Wulf-Johansson (1523_CR24) 2013; 8 T Bracht (1523_CR28) 2016; 14 G Urbonaviciene (1523_CR36) 2014; 48 SG Saekmose (1523_CR29) 2015; 10 MM McDermott (1523_CR4) 2006; 73 A Schlosser (1523_CR20) 2006; 64 C Diehm (1523_CR2) 2004; 33 TW Rooke (1523_CR16) 2011; 54 B Pilecki (1523_CR21) 2015; 70 MM McDermott (1523_CR13) 2004; 292 RF Doolittle (1523_CR19) 2012; 21 JB Joensen (1523_CR30) 2008; 196 G Urbonaviciene (1523_CR31) 2010; 210 C Molleken (1523_CR32) 2016; 33 AT Holm (1523_CR25) 2015; 308 P Lu (1523_CR35) 2011; 3 JW Olin (1523_CR15) 2016; 67 A Schlosser (1523_CR22) 2016; 36 L Norgren (1523_CR5) 2007; 45 B Pilecki (1523_CR23) 2016; 291 G Urbonaviciene (1523_CR38) 2011; 216 MS Conte (1523_CR8) 2015; 102 MS Conte (1523_CR9) 2015; 61 N Grondal (1523_CR1) 2015; 102 S Lock-Johansson (1523_CR26) 2014; 15 N Malyar (1523_CR11) 2013; 34 FG Fowkes (1523_CR12) 2008; 300 MM McDermott (1523_CR18) 2016; 21 I Graham (1523_CR3) 2007; 14 RD Malgor (1523_CR14) 2015; 61 M Lepantalo (1523_CR7) 1996; 11 |
References_xml | – volume: 49 start-page: 1257 issue: 4 year: 2009 ident: 1523_CR27 publication-title: Hepatology doi: 10.1002/hep.22764 contributor: fullname: C Molleken – volume: 64 start-page: 104 issue: 2 year: 2006 ident: 1523_CR20 publication-title: Scand J Immunol doi: 10.1111/j.1365-3083.2006.01778.x contributor: fullname: A Schlosser – volume: 308 start-page: L1114 issue: 11 year: 2015 ident: 1523_CR25 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00351.2014 contributor: fullname: AT Holm – volume: 55 start-page: 1394 issue: 5 year: 2012 ident: 1523_CR6 publication-title: J Vasc Surg doi: 10.1016/j.jvs.2011.11.061 contributor: fullname: J Jim – volume: 46 start-page: 829 issue: 13–14 year: 2016 ident: 1523_CR34 publication-title: Int J Parasitol doi: 10.1016/j.ijpara.2016.08.004 contributor: fullname: TA Pereira – volume: 196 start-page: 937 issue: 2 year: 2008 ident: 1523_CR30 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.02.025 contributor: fullname: JB Joensen – volume: 64 start-page: e1 issue: 1 year: 2016 ident: 1523_CR10 publication-title: J Vasc Surg doi: 10.1016/j.jvs.2016.03.420 contributor: fullname: MC Stoner – volume: 292 start-page: 453 issue: 4 year: 2004 ident: 1523_CR13 publication-title: JAMA doi: 10.1001/jama.292.4.453 contributor: fullname: MM McDermott – volume: 14 start-page: S1 issue: Suppl 2 year: 2007 ident: 1523_CR3 publication-title: Eur J Cardiovasc Prev Rehabil doi: 10.1097/01.hjr.0000277983.23934.c9 contributor: fullname: I Graham – volume: 61 start-page: 54S issue: 3 Suppl year: 2015 ident: 1523_CR14 publication-title: J Vasc Surg doi: 10.1016/j.jvs.2014.12.007 contributor: fullname: RD Malgor – volume: 17 start-page: 386 issue: 6 year: 2012 ident: 1523_CR17 publication-title: Vasc Med doi: 10.1177/1358863X12463491 contributor: fullname: WR Hiatt – volume: 216 start-page: 440 issue: 2 year: 2011 ident: 1523_CR38 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2011.02.016 contributor: fullname: G Urbonaviciene – volume: 33 start-page: 183 issue: 4 year: 2004 ident: 1523_CR2 publication-title: Vasa doi: 10.1024/0301-1526.33.4.183 contributor: fullname: C Diehm – volume: 21 start-page: 12 issue: 1 year: 2016 ident: 1523_CR18 publication-title: Vasc Med doi: 10.1177/1358863X15617541 contributor: fullname: MM McDermott – volume: 67 start-page: 1338 issue: 11 year: 2016 ident: 1523_CR15 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.12.049 contributor: fullname: JW Olin – volume: 36 start-page: 122 issue: 1 year: 2016 ident: 1523_CR22 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.115.306672 contributor: fullname: A Schlosser – volume: 291 start-page: 1103 issue: 3 year: 2016 ident: 1523_CR23 publication-title: J Biol Chem doi: 10.1074/jbc.M115.681775 contributor: fullname: B Pilecki – volume: 49 start-page: 903 issue: 12 year: 2016 ident: 1523_CR33 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2016.05.023 contributor: fullname: NU Hansen – volume: 61 start-page: 1S issue: 3 Suppl year: 2015 ident: 1523_CR9 publication-title: J Vasc Surg doi: 10.1016/j.jvs.2014.12.006 contributor: fullname: MS Conte – volume: 11 start-page: 153 issue: 2 year: 1996 ident: 1523_CR7 publication-title: Eur J Vasc Endovasc Surg doi: 10.1016/S1078-5884(96)80044-X contributor: fullname: M Lepantalo – volume: 15 start-page: 147 year: 2014 ident: 1523_CR26 publication-title: Respir Res doi: 10.1186/s12931-014-0147-5 contributor: fullname: S Lock-Johansson – volume: 14 start-page: 201 issue: 1 year: 2016 ident: 1523_CR28 publication-title: J Transl Med doi: 10.1186/s12967-016-0952-3 contributor: fullname: T Bracht – volume: 33 start-page: 41 issue: 1 year: 2016 ident: 1523_CR32 publication-title: Sarcoidosis Vasc Diffuse Lung Dis contributor: fullname: C Molleken – volume: 54 start-page: e32 issue: 5 year: 2011 ident: 1523_CR16 publication-title: J Vasc Surg doi: 10.1016/j.jvs.2011.09.001 contributor: fullname: TW Rooke – volume: 300 start-page: 197 issue: 2 year: 2008 ident: 1523_CR12 publication-title: JAMA doi: 10.1001/jama.300.2.197 contributor: fullname: FG Fowkes – volume: 8 start-page: e82243 issue: 12 year: 2013 ident: 1523_CR24 publication-title: PLoS ONE doi: 10.1371/journal.pone.0082243 contributor: fullname: H Wulf-Johansson – volume: 21 start-page: 1808 issue: 12 year: 2012 ident: 1523_CR19 publication-title: Protein Sci doi: 10.1002/pro.2177 contributor: fullname: RF Doolittle – volume: 45 start-page: S5 issue: Suppl S year: 2007 ident: 1523_CR5 publication-title: J Vasc Surg doi: 10.1016/j.jvs.2006.12.037 contributor: fullname: L Norgren – volume: 70 start-page: 862 issue: 9 year: 2015 ident: 1523_CR21 publication-title: Thorax doi: 10.1136/thoraxjnl-2014-206609 contributor: fullname: B Pilecki – volume: 73 start-page: S2 issue: Suppl 4 year: 2006 ident: 1523_CR4 publication-title: Cleve Clin J Med doi: 10.3949/ccjm.73.Suppl_4.S2 contributor: fullname: MM McDermott – volume: 219 start-page: 892 issue: 2 year: 2011 ident: 1523_CR37 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2011.09.016 contributor: fullname: G Urbonaviciene – volume: 10 start-page: e0140418 issue: 10 year: 2015 ident: 1523_CR29 publication-title: PLoS ONE doi: 10.1371/journal.pone.0140418 contributor: fullname: SG Saekmose – volume: 3 start-page: 12 year: 2011 ident: 1523_CR35 publication-title: Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005058 contributor: fullname: P Lu – volume: 48 start-page: 99 issue: 2 year: 2014 ident: 1523_CR36 publication-title: Scand Cardiovasc J doi: 10.3109/14017431.2014.891760 contributor: fullname: G Urbonaviciene – volume: 102 start-page: 902 issue: 8 year: 2015 ident: 1523_CR1 publication-title: Br J Surg doi: 10.1002/bjs.9825 contributor: fullname: N Grondal – volume: 210 start-page: 619 issue: 2 year: 2010 ident: 1523_CR31 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2009.12.030 contributor: fullname: G Urbonaviciene – volume: 34 start-page: 2706 issue: 34 year: 2013 ident: 1523_CR11 publication-title: Eur Heart J doi: 10.1093/eurheartj/eht288 contributor: fullname: N Malyar – volume: 102 start-page: 1007 issue: 9 year: 2015 ident: 1523_CR8 publication-title: Br J Surg doi: 10.1002/bjs.9848 contributor: fullname: MS Conte |
SSID | ssj0024549 |
Score | 2.3651876 |
Snippet | Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is... Background Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is... BACKGROUNDSymptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of symptomatic PAD is... Abstract Background Symptomatic peripheral artery disease (PAD) is an atherosclerotic occlusive disease affecting the lower extremities. The cause of... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 159 |
SubjectTerms | Angiogenesis Arteries Arteriosclerosis Atherosclerosis Biomarkers Cardiovascular disease Cardiovascular diseases Causes of Confidence intervals Diabetes Diagnosis Extracellular matrix Extremities Family medical history Hypertension Ischemia Liver cirrhosis Lower-extremity ischemia Matrix protein Medical records MFAP4 Mortality Occlusion Patients Peripheral artery disease Peripheral vascular diseases Plastic surgery Primary patency Proteins Reconstructive surgery Regression analysis Surgery Survival analysis Target recognition Vascular diseases Vascular surgery |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlh9JL6XedJkWFQqFgopUlWTompSEUtqem5CZGH6aB1huym0L-fWdk7bKmh1563JW82PM0nvdW42fG3mOVczktXDvEDgWKtqINnbOtSlnmLCAIS88OL7-ai0v15Upf7b3qi3rCJnvgKXAnkLJNAJ0GJ1SW0g2D7pSWSLP1YGFyAhVyK6a2Lnsoe-oe5sKakzVWNUMtlqiYUHm1ZlaFiln_37fkvZo075fcK0DnT9jjyhz56XTGT9mDPD5jD5d1b_w5-76k3rqBWvgR2tsWauBz4sWM4Xrkiv9GaVyw4Phxff_rZrMqnq2cDI-Lw8BPXro873ndunnBLs8_f_t00da3JrQR2cuG6LIwsVhwyn7AlAXXA4qsBAgKAERIIeaIwnBhkH_1ygUkTUKDFGGIQXcv2cG4GvNrxrVJ1ibjQrBKwYBsTAyQEUXhokpGNuzjNor-ZjLH8EVUWOOnkHsMuaeQe9OwM4rzbiL5WpcvEG1f0fb_QrthHwglT9mHUESoDxHg-ZKPlT_VylhkfK5v2NFsJmZNnA9vcfY1a9deIht0yB-daNi73TAdSZ1oY17dlTnSIg_u8CdeTctid0nSWasWdHQ_WzCza56PjNc_iqe3dk7h_fXwfwTpDXskaanTf0X2iB1sbu_yMVKnTXhbsuQPlB0W7A priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA5aQXyReu20VSIIgjCYySSZ5EmqWIqwPlnZt5DbaEFntrtbof--52Sz2w6CjzvJLMm55JwvOfOFkLcQ5UyKjan70AJAkZrVvjW6FjHxlJjzTOO3w7Nv6uxcfJ3LedlwW5Wyyu2amBfqOAbcIweQLpWB2G7Yx8VljbdG4elquULjPnnQYAew525-C7gEgJ9yktlo9WEFsU1hoSXgJsBftZrEokzZ_-_CfCcyTasm74Sh033yuOSP9GSj8CfkXhqekoezckL-jPyYYYVdj4X8oOBl7Yr4U6SZkuFioIL-BYCcNULh5-r6z2I9ZuZWirTHmWfgN821nte0HOA8J-enX75_PqvL3Ql1gBxmjUkzUyETcfKuB8d1pnMAtaID1Tjngos-pADwsFGQhXXCeEidmHSc-T542b4ge8M4pANCpYpaR2W810K4HnIy1rsEumQmiKh4Rd5vpWgXG4oMm6GFVnYjcgsityhyqyryCeW864js1vnBuPxpi7NYF5OGQbbSGSYS56bvZStgIrKVvXaiIu9QSxZ9EFQRXPmUAMaLbFb2RAqlIe8zXUWOJz3Bd8K0eatnW3x3ZW8trSJvds34JtajDWm8yn24hmy4hb94uTGL3ZS40Vo0-HY3MZjJnKctw8WvzOwtjRGwyh7-f1hH5BFHI8a9IH1M9tbLq_QKUqO1f53t_wbYSA5O priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA61gvgi3h2tEkEQhNFsJskkDyJVLEVYn1zpW8hVC3W27m7F_feek82uHSw-ziQzJOeS853JmS-EvIAoZ1KcmDaHDhIUqVnrO6NbERNPiTnPNP47PP2sjmfi04k82SPb462qAJdXpnZ4ntRscfb698_1O3D4t8XhtXqzhJilsIAS8iHIq1p1jVznEBixwmsq9F_qPVnQ8ET0ppWwCtRNzitfMQpThc3_3zX7UtAaF1ReilBHt8mtCi3p4cYW7pC9NNwlN6Z18_we-TrF4ruMNf6g-0XrqmZSpIWt4XSggv6C3Lkoi8Llcv3jfDUvpK4UGZELBcEZLWWga1r3du6T2dHHLx-O23qsQhsA3qwQTzMVCkcn7zOIyZneQRYWHWjNORdc9CEFyBwnCgBaL4wHVMWk48zn4GX3gOwP8yE9IlSqqHVUxnsthMsA11h2CdTMTBBR8Ya82krRnm_YM2zJOrSyG5FbELlFkVvVkPco511HJL4uN-aLb7b6kXUxaRhkJ51hInFucpadgInITmbtRENeopYsGgyoIrj6lwGMF4mu7KEUSgMkNH1DDkY9wa3CuHmrZ7u1SssBLhoAmIY15PmuGZ_EUrUhzS9KH64BKHfwiocbs9hNiRutxQSf7kcGM5rzuGU4_V5Iv6UxAhbgx_8f9RNyk6MR42cifUD2V4uL9BRQ08o_K77wBzvLEww priority: 102 providerName: Scholars Portal |
Title | Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29884190 https://www.proquest.com/docview/2056943590 https://search.proquest.com/docview/2052804537 https://pubmed.ncbi.nlm.nih.gov/PMC5994031 https://doaj.org/article/ade8daa35a904e229ff534527535f8a4 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_aDsZexr7nrQseDAYDN4osydJjU1rKIKWUdYS9CEmWu0DjhCQd9L_fSZFDzN72YrAlG-k-fL-zTj8DfMEop3w9UkXjSkxQuCSFLZUsWO2p98RYIsPe4cmVuLxl36d8egC82wsTi_adnZ209_OTdvY71lYu527Y1YkNrydnXCmGxjg8hEMMv12K3hHsYcaTli9HUgzXGNBEqK7EZAmTriL8s4gqKdkovIb3YlGk7P_3xbwXmfpVk3th6OIFPE_4MT_djvMlHPj2FTydpBXy1_BzEirsmlDIjwpeFSaJ39d5pGSYtTnL_2CCHDWS4-n6cb7cLCJzax5ojyPPwH0eaz0f87SA8wZuL85_nF0W6d8JhUMMswmgmQgXiThp1aDjGlUZTLVqg6oxxjhTW-cdpocjgSisYsoidCLcUGIbZ3n5Fo7aRevfQ85FLWUtlLWSMdMgJiON8ahLohyrBc3gWydFvdxSZOiYWkiht9LXKH0dpK9FBuMg513HwG4dLyxWdzrpWJvaSxxkyY0izFOqmoaXDCfCS95IwzL4GrSkgw-iKpxJWwlwvIHNSp9yJiTiPlVlcNzrib7j-s2dnnXy3bWmiAkVokhFMvi8aw53hnq01i8eYh8qEQ2X-Ih3W7PYTamzrgyqnsH05txvQUOPzN7JsD_8950f4RkNph4-E8ljONqsHvwnRE0bO0BfmVYDeDI-v7q-GcRvD3icMInHm_GvQfSiv3HqHLA |
link.rule.ids | 230,314,727,780,784,864,885,2102,12056,21388,24318,27924,27925,31719,31720,33744,33745,43310,43805,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3faxQxEB70CuqL-LOuVl1BEITF3G6STZ6klZZTe4dIK30L2SSrBd09765C_3tncrlrF8HH3WSXZCaT-SaZfAF4jV5OBz_WResqDFCEYkVTaVVwH8oQmG2YorPD05mcnPJPZ-IsLbgtU1rlZk6ME7XvHa2RY5AupEbfrtn7-e-Cbo2i3dV0hcZN2CHmdDGCnYPD2ZevV2x7GP6kvcyxku-W6N0kpVpi5IQRWCEH3iiS9v87NV_zTcO8yWuO6Oge3E0IMt9fq_w-3AjdA7g1TXvkD-HblHLsWkrlRxUvCpsUEHweSRnOu5znfzBEjjrJ8XF5-Wu-6iN3a07Ex5Fp4Gcesz0v87SF8whOjw5PPkyKdHtC4RDFrAg2M-kiFWdZt2i6VtcWgy1vUTnWWmd944LDAHEsEYfVXDcInpiwJWta14jqMYy6vgtPIBfSK-WlbhrFuW0RlbHWBtQm0457WWbwdiNFM1-TZJgYXChp1iI3KHJDIjcygwOS87Yi8VvHF_3iu0nmYqwPChtZCasZD2Wp21ZUHDsiKtEqyzN4Q1oyZIWoCmfTYQJsL_FZmX3BpULkp-sM9gY10XrcsHijZ5Osd2muxloGr7bF9CVlpHWhv4h1SoV4uMJf7K6HxbZLpVaKj-nrejBgBn0elnTnPyK3t9Ca4zz79P_Negm3JyfTY3P8cfb5GdwpaUDTypDag9FqcRGeI1BaNS-SNfwFSVASpA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZbB2UvY_d57TYPBoOBa0WWZOmx6xa6S0of1tE3oWsXaJyQpIX--x0pcojZ2x5tyUY6F5_vWEefEPoAUU56N5JVsA0kKEzgyjRSVNR54j3WBou4d3hyxk8v6PdLdrlz1Fcq2rdmetRdz4666Z9UW7mY2bqvE6vPJydMSgrGWC9cqO-jB6wBI-sT9Z5mD_KevIg5ErxeQVjjscYSUiZIvap4chGRQtBR_BjvRKRE3P_v53knPg1rJ3eC0fgxepRRZHm8Ge0TdM93T9H-JK-TP0O_J7HOLsRyflDzstJZCd6ViZhh2pW0vIU0OemlhMvV3Wyxnif-1jKSHye2gesyVXzelXkZ5zm6GH_9dXJa5RMUKgtIZh2hM-Y20XGSNoD7atlqSLicBgVpra12xnoLSeKIAxZrqTQAoDDTBJtgDWteoL1u3vlXqGTcCeG4NEZQqgMgMxy0B41iaanjpECfeimqxYYoQ6UEQ3C1kb4C6asofcUL9DnKedsxclynG_PllcqaVtp5AYNsmJaYekJkCKyhMBHWsCA0LdDHqCUVPRFUYXXeUADjjZxW6phRLgD9ybZAh4Oe4EF22NzrWWUPXikCyFAClpS4QO-3zfHJWJXW-flN6kMEYOIGXvFyYxbbKfXWVaB2YDCDOQ9bwNwTv3c279f__eQ7tH_-Zax-fjv7cYAekmj18b-ROER76-WNfwMwam3eJof5CwupG7k |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Microfibrillar-associated+protein+4+variation+in+symptomatic+peripheral+artery+disease&rft.jtitle=Journal+of+translational+medicine&rft.au=Hemstra%2C+Line+Ea&rft.au=Schlosser%2C+Anders&rft.au=Lindholt%2C+Jes+Sanddal&rft.au=Sorensen%2C+Grith+L&rft.date=2018-06-08&rft.pub=BioMed+Central+Ltd&rft.issn=1479-5876&rft.eissn=1479-5876&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1186%2Fs12967-018-1523-6&rft.externalDocID=A546892997 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon |